HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Terbutaline slow-release tablets in children with asthma. A comparison with t.i.d. beta 2-agonist therapy.

Abstract
The effects of 5 mg slow-release terbutaline sulphate tablets (Bricanyl Depot) given twice daily were compared with those of ordinary oral beta 2-agonist treatment given three times daily. The study was open, randomized and cross-over and was carried out over 8 weeks in 18 children with bronchial asthma. Compared with ordinary medication, the slow-release tablets obtained higher morning expiratory peak flow values and an improvement in the asthma symptoms during the night and during exercise (P less than 0.05). No differences were found in side effects in spite of a higher total daily dose during the period with terbutaline slow-release tablets. The slow-release tablets were preferred by 15 of 18 children and their families when the effects, side effects and dosage were evaluated.
AuthorsS Croner, M Gustafsson, N I Kjellman, L Säwedal
JournalAllergy (Allergy) Vol. 41 Issue 5 Pg. 331-4 (Jul 1986) ISSN: 0105-4538 [Print] Denmark
PMID2876658 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Adrenergic beta-Agonists
  • Delayed-Action Preparations
  • Dosage Forms
  • Terbutaline
  • Albuterol
Topics
  • Administration, Oral
  • Adolescent
  • Adrenergic beta-Agonists (pharmacology)
  • Albuterol (therapeutic use)
  • Asthma (drug therapy, genetics)
  • Child
  • Child, Preschool
  • Delayed-Action Preparations
  • Dosage Forms
  • Evaluation Studies as Topic
  • Humans
  • Peak Expiratory Flow Rate
  • Terbutaline (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: